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Protein losses during peritoneal dialysis. The losses of protein
into dialysate have been considered a major limitation of mainte-
nance peritoneal dialysis. We, therefore, undertook a compre-
hensive evaluation of protein losses in 30 patients undergoing
maintenance intermittent peritoneal dialysis (IPD), 12 patients
undergoing acute IPD, and 8 patients undergoing continuous
ambulatory peritoneal dialysis (CAPD). The weekly loss of
protein based upon the usual treatments per week was relatively
similar with the three modes of dialysis. Protein losses during
repeated dialyses were similar for a given patient, but there was
marked interpatient variation. During maintenance IPD, protein
loss was 12.9 (SD) 4.4 g per 10 hours of dialysis; albumin loss
was 8.5 g, and IgG loss was 1.3 g. Approximately 50% of the
protein loss was from the ascitic fluid accumulated during the
interdialytic interval, and concentrations of most proteins in the
ascitic fluid correlated with their serum levels. Serum protein
concentrations were in the low, normal range and did not change
during dialysis. The development of peritonitis markedly in-
creased protein losses. During acute IPD, 23.3 16.5 g of
protein were lost per 36 hours of dialysis, lower losses than those
previously reported. With CAPD, 8.8 1.7 g of protein were
removed per 24 hours; also immunoglobulin losses correlated
with their serum concentrations. The results of these studies
suggest that, in the absence of peritonitis, dialysate protein
losses do not appear to limit the usefulness of peritoneal dialysis.
Perte de protéines au cours de Ia dialyse péritonéale. Les pertes
de protéines au cours de Ia dialyse péritonéale sont une limitation
majeure de cette technique. Nous avons donc entrepris une
evaluation des pertes de protéines chez 30 malades soumis a Ia
dialyse péritonéale intermittente (IPD) de facon chronique, 12
malades en IPD de facon transitoire, et 8 malades soumis a la
dialyse ambulatoire continue (CAPD). La perte de protéines
hebdomadaire était similaire dans les trois modalités. La perte de
proteines au cours de dialyses répétées était semblable pour un
même malade, mais il existait des differences importantes d'un
malade a l'autre. Au cours de I'IPD chronique la perte de
proteines était de 12,9 (SD) 4,4 g par 10 heures de dialyse, dont
8,5 g d'albumine et 1.3 g d'IgG. Approximativement 50% de Ia
perte de protéines provenait du liquide d'ascite accumulé dans
l'intervalle inter-dialytique et Ia concentration de la plupart des
protéines dans le liquide d'ascite correspondait a leurs concen-
trations sériques. Les concentrations sériques de protéines
étaient relativement basses et n'ont pas eté modifiées par la
dialyse. Les péritonites ont considérablement augmenté la perte
de protéines. Au cours de l'IPD aiguë Ia perte de proteines a été
de 23,3 16,5 g par 36 heures de dialyse, des valeurs inférieures
a celles antérieurement publiees. Au cours de Ia CAPD Ia
soustraction de protéines a été de 8,8 1,7 g par 24 heures. Les
pertes d'immunoglohulines étaient aussi en rapport avec leurs
concentrations sériques. Les résultats de cette étude suggèrent
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que, en l'absence de péritonite, les pertes de protéines dans le
dialysat ne paraissent pas limiter l'utilité de la dialyse péritoné-
ale.
Intermittent peritoneal dialysis (IPD) whereby
serial, short-term exchanges of short dwell time are
used has been widely used for the treatment of
acute renal failure and the temporary and long-term
management of chronic renal failure. Continuous
ambulatory peritoneal dialysis (CAPD) was recent-
ly introduced as an alternative treatment for chronic
renal failure f1—31. This technique involves the
continuous presence of dialysate in the peritoneal
cavity. A major concern with both IPD and CAPD
has been the loss of protein into dialysate. With
IPD, these losses have been reported to vary from
0.5 to 4.5 g liter exchanged, with 20 to 200 g total
protein loss for a single 24- to 48-hour dialysis [4—
11]. With maintenance IPD, patients often devel-
oped progressive wasting or malnutrition [11], and
the losses of protein into dialysate may have made a
major contribution to these problems. There are
few data for protein losses during CAPD or mainte-
nance IPD with presently available catheters or
equipment [1, 121.
For these reasons, we evaluated protein losses
during IPD and CAPD. We define acute IPD as that
used temporarily for acute or chronic renal failure,
whereas maintenance IPD is that used for long-term
management of end-stage renal failure. Losses of
total protein, albumin, IgG, IgA, 1gM, transferrin,
C3, and C4 were measured. Attempts were made to
identify factors that influence these losses. The
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losses of total protein and albumin were substantial-
ly lower than those previously described during
acute IPD. In general, the rate of protein loss, per
hour of dialysis, was relatively similar for the three
types of peritoneal dialyses. The main factor that
increased protein loss was peritonitis. Rates of
protein loss were quite similar when measured in
the same patient at different times, but there was
marked interpatient variability.
Methods
One hundred and eighty-nine studies of protein
loss were carried out in 30 patients during mainte-
nance IPD at the VA Wadsworth Medical Center,
the UCLA Center for Health Sciences, and the
Klinikum Charlottenburg (KC). Similar techniques
were used in the Los Angeles hospitals, which are
referred to as LA. Unless otherwise indicated, the
patients were clinically stable and lacked evidence
of peritoneal inflammation. They underwent main-
tenance IPD either four to five (LA), or three (KC)
times a week. Studies were conducted in 8 patients
during 241 days of CAPD (LA) and in 12 patients
while they underwent treatments with acute IPD
(LA). The outpatients undergoing maintenance IPD
were admitted for each study. Studies were carried
out during acute IPD in 3 patients with acute renal
failure and 9 with chronic renal failure. Of the
patients, 39 were male and 11 were female; ages
ranged from 26 to 76 years.
The patients undergoing maintenance IPD and
CAPD had well-functioning Tenckhoff, silicone
rubber peritoneal catheters [131. For acute IPD, a
nylon catheter (Trocath, McGaw Labs, Irvine, Cali-
fornia) was inserted for each dialysis. In LA, main-
tenance IPD was carried out with the PDS 200, an
automatic peritoneal dialysis delivery apparatus
[141 (Physio-Control Corp., Redmond, Washing-
ton); dialysate was exchanged at an average rate of
3.7 liters/hour. At KC, dialysis was carried out with
the Peritokomb® semiautomatic machine (Fresen-
ius, Bad-Homburg, Federal Republic of Germany),
which controls the gravity flow of dialysate into and
out of the peritoneal cavity; dialysate exchange rate
averaged 5.4 liters/hour. In both KC and LA,
studies of protein loss during maintenance IPD
were conducted over 9 to 11 hours of dialysis. The
interdialytic interval was 14 to 72 hours in LA
(median, 48 hours) and uniformily was 36 hours at
KC.
The procedure for CAPD was that of Oreopoulos
et al [15] with an infusion of 2 liters of dialysate
three to five times each 24 hours and a dwell time of
4 to 8 hours. For acute IPD, 2-liter bottles of
dialysate were exchanged at 2 liters/hour by gravity
flow.
The concentration of dextrose in dialysate solu-
tions during maintenance IPD was 1.5 g/dl. For
acute IPD, 80% of the exchanges used 1.5% dex-
trose-containing dialysate, and 20% used 4.25%
dextrose. The average daily dextrose concentra-
tions during CAPD varied from 1.81 to 3.76 g/dl and
were adjusted to produce ultrafiltration rates of 0.7
to 2.9 liters/day.
Nine maintenance IPD patients at KC underwent
four studies with 10-hour dialyses to evaluate the
effect of varying the dextrose concentration. The
first peritoneal dialysis used 1.5% dextrose. This
was followed by a dialysis with either 2.8 or 4.25%
dextrose and then 1.5% dextrose for two subse-
quent dialyses.
Blood samples were obtained immediately before
dialysis in patients undergoing maintenance IPD or
acute IPD, and in the morning in patients on CAPD.
In 23 studies in 10 patients undergoing maintenance
IPD, samples of "ascitic" fluid, present in the
peritoneal cavity during the interdialytic interval,
were collected before dialysis.
Protein loss was studied during 11 episodes of
peritonitis. Each occasion was characterized by
cloudy, effluent dialy sate and a positive culture (10/
11 were due to staphlococcus). The 5 episodes in
the patients undergoing maintenance IPD were all
accompanied by fever and abdominal tenderness.
These signs were present in only one episode of
peritonitis in the patients undergoing CAPD; the
other patients were asymptomatic.
To evaluate the rate of protein loss during the
course of maintenance IPD, we obtained serial
samples of dialysate throughout 10-hour dialyses.
In KC, aliquots were obtained from the effluent
dialysate collected over each 100 mm of mainte-
nance IPD; in LA, aliquots of dialysate were taken
from each outflow over the first 2 hours and from
pooled 2-hour collections thereafter. Analysis was
carried out in each separate sample. In initial stud-
ies, 1% of each effluent dialysate was pooled as an
internal standard. Albumin loss determined from
the sum of individual samples correlated with that
determined from the pool, r = 0.99, P < 0.001.
In other studies with acute and maintenance IPD
and CAPD, a 1% aliquot of each dialysate drainage
was collected and pooled for 30 to 72 hours during
acute and maintenance IPD, and the aliquots were
refrigerated immediately.
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interpatient variability (Fig. 1). Thus, the average
losses of total protein varied from 6.1 to 24.1 g/
dialysis in individual patients at KC, and the aver-
age losses of albumin varied from 2.5 to 20 g/
dialysis in separate patients in LA. The losses of
IgG, IgA, and transferrin are shown in Table 1; at
KC and LA the quantities of IgG and IgA lost per
dialysis were each not significantly different. As
with total protein and albumin, there was consider-
able interpatient variation in the quantity of these
proteins lost, but an individual patient generally lost
similar quantities of each of the proteins during
repeated dialyses.
The rates of loss of protein and albumin during
the course of individual 10-hour dialyses are shown
in Fig. 2. Protein loss was greatest during the initial
2 hours of dialysis, with approximately 50% of the
loss occurring during this time; subsequently the
rate decreased to become almost constant after 4
hours.
The concentrations of proteins in the ascitic fluid
of 10 patients are shown in Table 2. The greater
quantities of protein lost during the initial 100 to 120
mm of dialysis almost certainly reflects the higher
concentrations of proteins in this residual peritoneal
fluid, which is washed out during the first several
exchanges. The losses of IgG, IgA, and transferrin
were also substantially higher during the first 100 to
120 mm of dialysis, with the rate decreasing to a
stable value in each patient.
During maintenance IPD, there were no relation-
ships between the total dialysate losses of total
protein, albumin, or transferrin and the serum con-
centrations of the proteins. The serum IgA/IgG
ratio correlated with the ratio of the losses of these
proteins in dialysate (r = 0.97, P < 0.001). The
concentrations of protein in the ascitic fluid that
Total protein was measured by the Biuret method
[16], albumin with bromcresol green [171, and IgG,
IgA, 1gM, transferrin, C3, and C4 by radial immuno-
diffusion with end-point plates [18] (Endoplates®,
Kallestad Labs). Effluent dialysate was concentrat-
ed 40 times with Amicon ultrafiltration cells with a
PM-b membrane, which retains proteins with a
mol wt greater than 10,000 daltons. Preliminary
studies demonstrated the recovery of 92 to 97% of
1311-albumin added to solutions concentrated in this
manner. Concentrations of 1gM, C3, and C4 were
measured in outflow dialysate obtained during the
first 2 hours of IPD; subsequently, the concentra-
tions in dialysate concentrates were below 35 mg/dl
for 1gM; 25 mgldl for C3, and 5 mg/dl for C4, the
lower detection limits.
Informed consent was obtained prior to the
study. The data were evaluated by Student's t test,
paired t test, and linear regression analysis. Data
are given as mean SD, unless indicated other-
wise.
Results
Protein losses during maintenance intermittent
peritoneal dialysis (IPD). The losses of total protein
and albumin, measured respectively in 18 and 12
individual patients, are shown in Fig. 1 and Table 1.
During peritoneal dialysis, which lasted 10 hours,
the average loss of total protein was 12.9 4.4 g,
and the loss of albumin was 8.5 5.3 g. In
individual patients, there was usually little variation
in the quantity of total protein or albumin lost
during successive dialyses. Thus, the coefficient of
variation for total protein and albumin averaged
15.5 and 16.5%, respectively (range, 7 to 38% and 6
to 36%). On the other hand, there was substantial
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Fig. 1. Losses of total protein and albumin during maintenance intermittent perironeal dialysis. Each bar represents a mean value for an
individual patient, and each dot represents a separate measurement in the same patient. Serum concentrations of total protein and
albumin are given below the bar. The measurements of losses of total protein and albumin were carried out in different patients.
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Table 1. Protein loss during different types of peritoneal dialysisa
accumulated during the interdialytic interval corre-
lated with the respective serum concentrations for
all proteins except C3 (Table 2). The concentrations
of the proteins in ascitic fluid were 20 to 50% of
their respective serum concentrations. For the lin-
ear relationships between the ascitic fluid protein
concentration and the respective protein concentra-
tion in serum, higher concentration ratios (that is,
greater slopes) were found for albumin and transfer-
rin, proteins with the lowest molecular weights; the
slopes were substantially lower for the larger pro-
teins.
In 13 patients, the losses of total protein were
studied periodically over intervals up to 9 months.
Two weeks after catheter insertion, the average loss
of protein was 13.7 5.5 g/dialysis but decreased
to 12.2 4.9 g/dialysis 1 month after starting
dialysis (P < 0.05, by paired t test). Thereafter,
there was no change in protein losses. In 3 other
patients, albumin losses were measured repeatedly
during two periods of time, which were separated
by intervals of 11, 21 and 18 months, respectively.
The albumin losses at the two separate times in
these 3 patients were 10.9 and 9.4 2.9, 7.3 and 7.1
1.4, and 6.5 1.8 and 7.3 2.3 g per 10-hour
dialysis, respectively. Thus, protein losses appar-
ently were not affected by the duration of dialysis
and were stable in individual patients free of perito-
neal inflammation.
The effect of increasing the dextrose concentra-
tion in dialysate from 1.5 to either 2.8 (7 studies) or
4.25 g/dl (6 studies) on protein losses is shown in
Maintenance IPD
LA
Single dialysis
Acute IPD
KC Loss!weekb
ND 12.9 1.1
(99)
ND
CAPD
Loss!
weekc
8.5 1.5
(54)
1.28 0.29
(54)
182
(54)
ND
Total protein, g
Albumin, g
IgG, g
IgA, mg
1gM, mg
Transferrin, mg
C3, mg
C4, mg
Daily loss (LA)
1.30 + 0.15
(13)
392
(13)
ND
Loss!
weeka
Single dialysis
(LA)
45 22.3 4.7
(23)
30 13.3 2.4
(23)
4.6 2.87 0.78
(24)
800 547 189
(21)
ND ND
928 ND
ND
ND
ND 265
(12)
ND ND ND
ND ND ND
34 8.8 0.5
(110)
20 5.7 0.4
(110)
4.3 1.25 0.20
(110)
821 173 21
(110)
ND 71
(110)
ND 333
(110)
ND 70
(110)
ND 21 2.1
(110)
62
40
8.8
1211
497
2331
490
147
a All values are mean SEM. Values in parenthesis indicate total number of studies during which this protein was measured.
Abbreviations are IPD, intermittent peritoneal dialysis; CAPD, continuous ambulatory peritoneal dialysis; LA, Los Angeles; KC,
Klinikum Charlottenburg; ND, no data.
b Dialysis was every other day.
Dialysis was three times every 2 weeks.
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Fig. 2. Rates of loss of total protein and albumin during a single
peritoneal dialysis lasting 10 hours in patients treated with
maintenance intermittent peritoneal dialysis. Bars represent
mean values, and individual points represent separate measure-
ments.
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Table 2. Relationship between protein concentrations in ascitic fluid and serum in patients undergoing maintenance intermittent
peritoneal dialysisa
.Albumin
gidI
IgG IgA
.__________________________________
1gM Transferrin C1
__________________
C4
mgldl
Serumb 3.71 0.50 936 295 159 55 117 50 195 37 99 21 38 9
Ascitic fluid 1.86 0.65 355 180 54 27 29 18 87 30 20 10 12 6
Slope,fluidlserum 0.50 0.35 0.31 0.37 0.59 0.00 0.43
Correlation coeff., r 0.67c 0.55 Q74C 0.62' 0.77c 0.01 0.60'
Mol wt, daltons 60,000 150,000 160,000 900,000 90,000 185,000 240,000
a Data for serum and ascitic fluid are mean SD of 25 comparison.
b Blood was drawn before a single IPD treatment.
P <0.01.
Dialysate 1.5 2.8 4.25
Lose,% • 0
Fig. 3. With an increase in dextrose concentration
to 2.8 or 4.25%, protein loss increased by 39 18
and 34 10%, respectively; with the return to 1.5
dextrose 2 days later, the total protein losses were
still 12 10% higher (P < 0.05, by paired t test).
Protein losses returned to values not different from
baseline after 5 days. During the hypertonic dialy-
sis, the concentration of protein increased in the
effluent dialysate, indicating that the higher protein
losses were not due simply to increased ultrafiltra-
tion. Also, the increased protein losses observed 2
days after the hypertonic glucose could be account-
ed for by an increase in protein loss in the first 10
liters of dialysate, an observation suggesting that a
higher protein concentration was present in the
I I
1 2 34 5 6 7
Time, weeks
Fig. 4. Quantities of protein lost during five episodes of peritoni-
tis in 4 patients undergoing maintenance intermittent peritoneal
dialysis. The presence of clinical peritonitis as defined in meth-
ods is indicated by the brackets.
peritoneal fluid that accumulated during the inter-
dialytic period.
Serial losses of total protein were measured in 4
patients undergoing maintenance IPD before and
following episodes of clinically apparent peritonitis.
The baseline losses of total protein varied from 6.4
to 18.4 g/dialysis; during peritonitis, the losses
increased to a maximum of 34 to 48 g per 10-hour
dialysis (Fig. 4). Serial albumin losses were mea-
sured in one patient who had mild peritonitis mani-
fested only by fever and cloudy dialysate. Albumin
loss increased from 7 to 26 g/dialysis, but the
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Fig. 3. Dialysate protein losses during sequential treatment with
maintenance intermittent peritoneal dialysis as dialvsate glucose
was increased from 1.5 to 2.8 or 4.25 gidI for a single dialysis.
Each point represents a separate patient, and the horizontal lines
represent mean values for each study.
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Fig. 5. Losses of various proteins in 12 patients treated with
acute intermittent peritoneal dialysis. The bar represents mean
values, whereas separate determinations during individual dialy-
sis are indicated by single data points. ND is no data.
greatest loss did not occur until 4 to 8 weeks after
treatment of the peritonitis and resolution of the
fever. In 3 of 5 patients, protein losses returned to
baseline during a period of 3 to 13 weeks.
The serum concentrations of total protein, albu-
min, 1gM, transferrin, and C3 in these patients
undergoing maintenance IPD were below normal.
During a dialysis treatment, there were no changes
in any serum protein measured except transferrin,
which decreased by 4% (P < 0.01). Serum proteins
were monitored serially in 13 other patients fol-
lowed over 9 months of treatment with maintenance
IPD. In these patients, the serum protein concentra-
tions did not change significantly.
For the patients undergoing maintenance IPD,
there was no relationship between the losses of total
protein or albumin and the patients' age, sex,
weight, body surface area, the etiology of renal
failure, or the peritoneal clearance of urea or creati-
nine. Also, there was no relationship between albu-
min loss during dialysis and the length of the
interdialytic interval or the interdialytic weight
gain.
Protein losses during acute intermittent peritone-
a! dialysis. The protein losses into the peritoneal
dialysate during acute IPD, which used intermittent
insertion of a nylon catheter and "manual" ex-
change of 2-liter bottles, are shown in Fig. 5. Each
dialysis lasted 20 to 70 hours, but the data have
been normalized to 36 hours, a common length of
treatment. Total protein losses varied from 6.4 to
44.6 g per 36-hour dialysis, whereas albumin losses
varied from 3.6 to 28.2 g. The losses of lgG varied
widely from patient to patient and were below 3 g/
dialysis except in 2 patients. The losses of IgA
varied from 104 to 1538 mg per 36-hour dialysis.
There was no relationship between losses of various
proteins and their respective serum concentrations.
Serum protein concentrations, measured before and
after dialysis during nine dialyses in 5 patients,
showed no change in total protein, albumin, IgG,
IgA, 1gM, transferrin, C3, or C4.
Protein losses during CAPD. The results of 13
studies in 8 patients undergoing CAPD revealed
considerable interpatient variation in the quantity of
each protein lost (Table 3). The daily losses were
relatively constant in the same patient. Thus, the
coefficient of variation for albumin loss in individual
patients averaged 8.4 3.3%.
Total protein losses ranged from 5.5 to 11.8 g per
24 hours (mean, 8.8 1.7 g). Albumin accounted
for 50 to 79% of protein loss, and IgG accounted for
5 to 28%. The sum of individual proteins equaled 85
4.8% of total protein loss.
Mean serum protein concentrations in these pa-
tients are shown in Table 3. For total protein,
albumin, IgA, transferrin, C3, and C4, there was no
relationship between the quantity lost and serum
concentration. The losses of IgG and 1gM were
correlated with the serum concentrations with: IgG
loss (mg/day) = 1.21 (serum IgG, mg/do — 338; (r
= 0.71, P < 0.01); and 1GM loss (mg/day) = 0.30
(serum 1gM, mg/do + 4.8 (r = 0.59, P < 0.05). The
S
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Table 3. Losses of serum proteins into dialysate and serum protein concentrations during continuous ambulatory peritoneal dialysisa
Total
Patient Study days
protein Albumin IgG IgA 1gM Transferrin C3 C4
giday mg/day
1 14 9.9 2.4 7.8 1.6
Dialysate losses
0.78 0.03 211 81 43 26 315 112 86 43 27 12
2 21 6.9 0.2 4.3 0.3 0.98 0.05 111 10 118 9 187 17 49 3 17 2
20 12.0 2.8 7.6 1.5 0.99 0.49 215 57 258 66 356 74 112 39 17 I
3 21 7.9 0.7 5.3 0.4 1.07 0.12 66 8 36 13 374 67 40 8 21 4
4 18 10.8 1.4 5.4 1.0 2.96 0.47 213 43 68 27 366 93 90 28 29 8
33 9.3 0.9 5.6 0.5 1.98 0.64 158 39 47 24 295 97 64 35 18 10
5 14 8.2 0.5 5.2 0.7 1.22 0.25 205 48 74 14 407 87 54 14 17 3
21 10.3 1.4 6.7 0.8 1.72 0.34 313 62 120 32 483 88 106 35 30 8
6 14 9.4 2.2 6.6 1.7 0.55 0.17 130 33 24 34 351 34 85 28 29 8
7 7.6 0.1 5.4 0.3 0.40 0.01 92 3 12 0 313 20 63 9 24 3
7 14 5.5 0.6 3.3 0.5 0.70 0.10 100 25 26 12 203 77 31 13 6 3
21 7.6 0.5 4.8 0.4 0.92 0.12 154 27 64 17 358 42 56 15 10 3
8 21 8.8 0.7 5.5 0.6 1.98 0.19 289 34 31 8 325 45 69 17 27 5
Mean SD 8.8 1.7 5.7 1.3 1.25 0.72 173 76 71 66 333 78 70 25 21 8
6.6 0.5
gIdl
3.5 0.4
g/dl
Serum protein concentrations
1.41 0.42 220 65
g/dI mg/dl
234 131
mg/dl
228 40
mg/dl
107 20
mg/dl
32 6
mg/dl
a All data are mean SD.
interpatient variations in serum IgG and 1gM ex-
ceeded those for other proteins, a factor that may
have accounted for correlations between serum
concentration and peritoneal loss.
Outflow volume, which varied from 7.7 to 12.9
liters/day during CAPD, showed no relation to
protein loss. In patients 4 and 6, the exchange
number increased from 4 to 5/day without changing
protein loss. PatientS used 6 and 8 liters of dialysate
on alternate days; his outflow volume varied by 2.4
liters/day, but protein losses did not change. For the
group of patients, the losses of proteins did not vary
with the mean dialysate glucose concentration, the
body surface area, or the dietary protein intake.
Dialysate protein, losses, measured in 3 patients
during six episodes of peritonitis during CAPD are
shown in Fig. 6. Except in one occasion (patient
3A), the episodes of peritonitis were mild, charac-
terized by a positive culture with cloudy fluid but no
fever or symptoms. Antibiotics were administered
within 24 hours of the appearance of cloudy fluid
except in patient 2. With antibiotic treatment, pro-
tein losses decreased from 15.1 3.6 to 9.1 0.8
g/day except in patient 2, whose maximal protein
loss was 10.0 g/day, which fell to 8.8 0.7 g/day
after treatment. This asymptomatic patient had a
long history of cloudy fluid and a positive culture
for Staphiococcus a/bus.
Pt. 1
o 6 8
Pt. 2
0
Pt. 3A
20
15
5
0 2 4 6 8
20
._. Pt. 3B
.
10]
_j•••/• \•\••_•/•/••215,
I 0-0-0
101 ooA\Afr\O/O
4f 8 12 16 f20
Time, days
Fig. 6. Daily peritoneal losses of protein in 4 patients who
developed peritonitis during continuous ambulatory peritoneal
dialysis. The solid bar indicates a period of peritonitis. For
patient 38, who received Cephadyl, l-g doses iv. (1) and 50 mg/
liter in the dialysate, there were three recurrences. Inpatient 3B,
the dialysate glucose concentration was either 2.3 (LID, 2.8 (s), or
3.8 g/dl (0).
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In patient 3B, cloudy fluid developed three times
over a 21-day period, probably due to inadequate
antibiotic dosage. Protein loss increased, and dialy-
sate outflow volume fell even with an increased
dialysate dextrose concentration.
Comparison of protein losses with the three types
of peritoneal dialysis. The average weekly losses of
various proteins were calculated under an assump-
tion that maintenance IPD is performed every other
day for 10 hours, acute IPD is carried out three
times every 2 weeks for 36 hours, and CAPD is
carried out every day (Table 1). During mainte-
nance IPD, the losses of total protein and albumin
averaged 12.9 and 8.5 g per 10-hour dialysis, values
that extrapolate to 45 and 30 glweek. With acute
IPD, the average protein loss was 22.3 g per 36
hours of dialysis, or 34 g/week. The weekly losses
of total protein and albumin with CAPD extrapolat-
ed to 62 and 40 g/week. With extrapolation over an
entire week, the rates of total protein loss were 0.27
g/hour with maintenance IPD, 0.20 g/hr with acute
IPD, and 0.37 g/hr with CAPD. During maintenance
IPD, the rate of loss of immunoglobulins, IgG and
IgA, expressed for 10-hour dialysis, were similar to
losses over 24 hours of CAPD. During acute IPD,
the losses of IgG and IgA, expressed per 36 hours of
dialysis, were two to three times greater than those
with the other modes.
Discussion
The present study represents a comprehensive
evaluation of losses of plasma proteins during three
types of peritoneal dialysis: acute intermittent pen-
toneal dialysis (IPD), maintenance IPD, and contin-
uous ambulatory peritoneal dialysis (CAPD). Pro-
tein losses were significantly lower than those pre-
viously reported. The losses of total protein,
albumin, IgG, and IgA, extrapolated to the number
of treatments carried out each week, did not differ
greatly with the three modes of dialysis. With each
mode of dialysis, losses were quite similar when
repeated measurements were made in the same
patient, but there is considerable interpatient varia-
tion. The major factor found to influence protein
loss is peritonitis. The results also indicate that
serum protein concentrations remain stable over a
single peritoneal dialysis and during 9 months with
maintenance IPD.
Previous studies of protein loss during acute IPD
were usually made during infrequent treatments and
with insertion of a peritoneal catheter for each
dialysis [4—9, 11]. With such techniques, peritonitis
was frequent [7, 11]. Peritonitis or peritoneal in-
flammation from other causes, such as low grade
bleeding and/or increased permeability of serous
membranes as may occur with marked uremia, may
have contributed to the large protein losses in
earlier reports.
It has also been suggested that the composition of
the catheter might affect protein losses [19]. In the
present study, the rate of protein loss did not differ
in acute IPD with nylon catheters, compared with
maintenance IPD with silicone rubber catheters, an
observation suggesting that catheters of these com-
position do not affect protein loss.
Protein losses have been reported to be 16 to 22 g
during 10 hours of maintenance IPD [12] and 12 to
19 g during 24 hours of CAPD [1]. In the present
study, slightly lower rates of loss were found in a
larger number of patients. The observed losses of
IgG and IgA are substantially lower than is the
mean loss of 20.5 g of immunoglobulin reported by
McKelvey et al [201 during 30 hours of acute IPD;
the reason for this discrepancy is unclear. The
losses of other proteins (transferrin, 1gM, C3, and
C4) were quite small. The serum concentrations of
these proteins were not altered during a single
peritoneal dialysis. This is not surprising because
the quantities lost during peritoneal dialysis are
similar to those in 50 to 200 ml of plasma (Table I).
The present study provides insight into the role of
factors, such as the dialysate tonicity, peritonitis,
and interpatient variation, which may affect protein
losses. Our data confirm previous observations that
the dialysate protein concentration increases as the
concentration of glucose is elevated [171. When
glucose concentration was reduced, the increased
protein losses did not persist into the next dialysis;
this contrasts to the sustained increase in urea
permeability after use of hypertonic solutions [211.
The small changes in dialysate glucose concentra-
tions used in individual patients undergoing CAPD
were not associated with variation in protein losses;
however, dialysate glucose levels were not specifi-
cally altered to study this effect.
Protein losses increased substantially during peri-
tonitis, although the values did not approach the 100
to 300 g/dialysis reported previously l22]. Protein
losses during IPD may be elevated for several
weeks after successful treatment of peritonitis. Dur-
ing peritonitis with CAPD, the increased losses
generally returned to baseline within a few days of
antibiotic treatment. Peritonitis was milder during
CAPD and was generally treated within a few hours
after the appearance of cloudy dialysate. During
IPD, the infection appeared during the 2- to 3-day
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interdialytic interval, a fact that delayed both the
recognition and treatment of peritonitis; this may
have contributed to the more persistent protein
losses after peritonitis during IPD.
The present results indicate that there is sus-
tained variability in protein losses from one patient
to another. Thus, interpatient variation of protein
losses reached 300% during maintenance IPD and
200% during CAPD. Such variability in the perito-
neal losses of protein is greater than the variations
in permeability reported for smaller molecules,
such as urea or creatinine 1123]. On the other hand,
there was usually little variation in protein losses in
the same patient studied serially with either mainte-
nance IPD or CAPD, unless peritonitis supervened.
The reasons for the interpatient variation are not
apparent; the age of the patient, body weight, body
surface area, and the etiology of renal disease all
had no influence on the rates of protein losses. Our
observation of marked interpatient variation in the
rates of protein loss indicate that protein losses are
best studied when a patient is usecL as his own
control. The comparison of one group of patients to
another may not yield meaningful results.
The serum protein concentrations appeared to
have little influence on protein losses. The protein
loss during maintenance IPD was greatest during
the initial 100 to 120 mm of dialysis, probably due to
the "wash-out" of collected ascitic fluid containing
higher protein concentration. Over the last 6 hours
of IPD, the rate of loss was stable, suggesting that
proteins diffuse into the peritoneal cavity at a
relatively constant rate. The development of ascitic
fluid with a high protein concentration may explain
the greater protein loss per hour during mainte-
nance IPD compared with acute IPD. During the
last 6 hours of maintenance IPD, the protein losses
were 0.76 0.25 g/hour, a value which is remark-
ably similar to the losses of 0.62 0.46 g/hour
during acute IPD.
The close correlation between serum protein con-
centrations and the concentrations of these proteins
in ascitic fluid (Table 2) and the direct correlation
between the loss of IgG and 1gM and the respective
serum concentrations during CAPD provide addi-
tional evidence for a passive nature of protein
losses.
The presence of end-stage renal failure with per-
sistent azotemia may contribute to altered protein
metabolism and slightly reduced serum protein lev-
els in our patients [24]. The magnitude of dialysate
protein losses suggests a need for greater protein
intake in patients undergoing peritoneal dialysis
compared with that in patients undergoing hemodi-
alysis. Nonetheless, dialysate protein losses may
not be the major factor limiting the usefulness of
these treatment modalities.
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